Cargando…
Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19
BACKGROUND: Coronavirus disease 19 (COVID‐19)–associated coagulopathy is a hallmark of disease severity and poor prognosis. The key manifestations of this prothrombotic syndrome—microvascular thrombosis, stroke, and venous and pulmonary clots—are also observed in severe and catastrophic antiphosphol...
Autores principales: | Hollerbach, Anne, Müller‐Calleja, Nadine, Pedrosa, Denise, Canisius, Antje, Sprinzl, Martin F., Falter, Tanja, Rossmann, Heidi, Bodenstein, Marc, Werner, Christian, Sagoschen, Ingo, Münzel, Thomas, Schreiner, Oliver, Sivanathan, Visvakanth, Reuter, Michael, Niermann, Johannes, Galle, Peter R., Teyton, Luc, Ruf, Wolfram, Lackner, Karl J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420426/ https://www.ncbi.nlm.nih.gov/pubmed/34242469 http://dx.doi.org/10.1111/jth.15455 |
Ejemplares similares
-
Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study
por: Kremer, Wolfgang M., et al.
Publicado: (2021) -
Diabetes Mellitus and Its Association with Adverse In-Hospital Outcomes in Patients with COVID-19—A Nationwide Study
por: Schmitt, Volker H., et al.
Publicado: (2023) -
No Evidence for Classic Thrombotic Microangiopathy in COVID-19
por: Falter, Tanja, et al.
Publicado: (2021) -
Obesity and Its Impact on Adverse In-Hospital Outcomes in Hospitalized Patients With COVID-19
por: Keller, Karsten, et al.
Publicado: (2022) -
Antiphospholipid Antibodies: Their Origin and Development
por: Lackner, Karl J., et al.
Publicado: (2016)